Genprex Competitors and Similar CompaniesClear all

Genprex's competitors and similar companies include Oragenics, Qu Biologics and Bluebird Bio.
Genprex
Genprex
Genprex is a gene therapy company developing treatments for cancer and diabetes.
Oragenics
Oragenics
Oragenics provides a novel antibiotics against infectious disease and develops effective treatments for oral mucositis.
Qu Biologics
Qu Biologics
Qu Biologics is a company that develops immunotherapies designed to restore normal immune function.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
Founding Date
Founding Date
2009
Founding Date
1996
Founding Date
2007
Founding Date
1992
Type
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
West Lake Hills, US HQ
Austin, US
Locations
Tampa, US HQ
Locations
Burnaby, CA HQ
Locations
Somerville, US HQ
Employees
Employees
2865% increase
Employees
717% increase
Employees
2013% decrease
Employees
32338% decrease
Valuation ($)
Valuation ($)
5.4 m
Valuation ($)
13.6 m
Valuation ($)
N/A
Valuation ($)
192.1 m
Twitter followers
Twitter followers
2.1 k
Twitter followers
44
Twitter followers
849
Twitter followers
10.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
6.9
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
87.5%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
75%

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$37.7k (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$3.6m (FY, 2022)
Net income
Net income
($30.9m) (FY, 2023)
Net income
($20.7m) (FY, 2023)
Net income
N/A
Net income
($266.6m) (FY, 2022)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 9.9m
Total funding raised
N/A
Total funding raised
$ 409m
For sources of this data, please see the company profile

View Company Profiles

Oragenics
HQ
Tampa, US
Employees
7↑ 17% increase

Oragenics provides a novel antibiotics against infectious disease and develops effective treatments for oral mucositis.

View company
Qu Biologics
HQ
Burnaby, CA
Employees
20↓ 13% decrease

Qu Biologics is a company that develops immunotherapies designed to restore normal immune function.

View company
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease

Bluebird Bio is a developer of gene therapies for severe genetic diseases.

View company